InflaRx IFRX
NASDAQ IFRX
$1.54 +0.09 (+6.21%)
At close: Oct 20, 2026 · 4:00 PM EDT

InflaRx (IFRX) Total Debt (2018 - 2026)

Updated

InflaRx's Total Debt came in at $5.15 million for Q2 2025.

Analysis

InflaRx (IFRX) Total Debt (2018 - 2026) Analysis & Trends

At the end of FY2021, InflaRx's Total Debt was $158,104, up 12.6% from FY2020.

  • Going back by year, Total Debt was $140,365 in FY2020, -$235,127 in FY2019, $364,479 in FY2018 and -$33,907 in FY2017.
  • The Q2 2025 figure represents the highest quarterly Total Debt in data going back to Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 49.04 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 70.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 26.25 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 63.19 Bn
10 InflaRx 105.98 Mn -227.64 Mn 2.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 6.02 Mn
Dec 31, 2025 6,815.93 Bn
Jun 30, 2025 5.34 Mn
Sep 30, 2022 140,824.11
Jun 30, 2022 136,158.78
Mar 31, 2022 146,624.10
Dec 31, 2021 156,518.68
Jun 30, 2021 148,752.68
Mar 31, 2021 419,959.43
Dec 31, 2020 144,802.99
Jun 30, 2020 504,001.75
Mar 31, 2020 119,372.81
Dec 31, 2019 118,334.35
Dec 31, 2018 352,960.08
API Access

InflaRx Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=IFRX&period=max&api_key=YOUR_API_KEY